Edit Olasz

1.7k total citations
34 papers, 976 citations indexed

About

Edit Olasz is a scholar working on Immunology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Edit Olasz has authored 34 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Pathology and Forensic Medicine and 7 papers in Dermatology. Recurrent topics in Edit Olasz's work include Autoimmune Bullous Skin Diseases (7 papers), Urticaria and Related Conditions (6 papers) and Dermatologic Treatments and Research (5 papers). Edit Olasz is often cited by papers focused on Autoimmune Bullous Skin Diseases (7 papers), Urticaria and Related Conditions (6 papers) and Dermatologic Treatments and Research (5 papers). Edit Olasz collaborates with scholars based in United States, Hungary and United Kingdom. Edit Olasz's co-authors include Kim B. Yancey, Robert L. Truitt, Zelmira Lazarova, Hiroshi Shimizu, Masashi Akiyama, Wataru Nishie, Akihiko Shibaki, Daisuke Sawamura, Maki Goto and Michael D. Rosenblum and has published in prestigious journals such as Nature Medicine, Blood and The Journal of Immunology.

In The Last Decade

Edit Olasz

32 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edit Olasz United States 17 302 260 249 242 168 34 976
Ana María Abreu Vélez United States 16 553 1.8× 94 0.4× 333 1.3× 337 1.4× 83 0.5× 104 928
Makoto Inaoki Japan 16 416 1.4× 900 3.5× 204 0.8× 289 1.2× 348 2.1× 41 1.6k
Alain Réano France 17 166 0.5× 263 1.0× 83 0.3× 94 0.4× 357 2.1× 43 1.2k
David T. Woodley United States 12 341 1.1× 58 0.2× 225 0.9× 232 1.0× 156 0.9× 13 823
Duco Kramer Netherlands 20 173 0.6× 251 1.0× 114 0.5× 98 0.4× 337 2.0× 35 1.0k
S Morioka Japan 18 567 1.9× 45 0.2× 389 1.6× 283 1.2× 182 1.1× 35 1.1k
Kay H. Singer United States 19 157 0.5× 548 2.1× 96 0.4× 113 0.5× 218 1.3× 28 1.2k
Sivan Harel United States 13 238 0.8× 305 1.2× 68 0.3× 114 0.5× 529 3.1× 28 1.7k
Hideoki Ogawa Japan 15 493 1.6× 51 0.2× 308 1.2× 225 0.9× 138 0.8× 46 930
R.A.J. Eady United Kingdom 21 555 1.8× 102 0.4× 142 0.6× 210 0.9× 406 2.4× 40 1.5k

Countries citing papers authored by Edit Olasz

Since Specialization
Citations

This map shows the geographic impact of Edit Olasz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edit Olasz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edit Olasz more than expected).

Fields of papers citing papers by Edit Olasz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edit Olasz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edit Olasz. The network helps show where Edit Olasz may publish in the future.

Co-authorship network of co-authors of Edit Olasz

This figure shows the co-authorship network connecting the top 25 collaborators of Edit Olasz. A scholar is included among the top collaborators of Edit Olasz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edit Olasz. Edit Olasz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quirk, Brendan J., Edit Olasz, Suresh N. Kumar, Donald Basel, & Harry T. Whelan. (2021). Photodynamic Therapy for Benign Cutaneous Neurofibromas Using Aminolevulinic Acid Topical Application and 633 nm Red Light Illumination. Photobiomodulation Photomedicine and Laser Surgery. 39(6). 411–417. 11 indexed citations
2.
Schulman, Joshua M., et al.. (2018). Response of Cutaneous Squamous Cell Carcinoma to Treatment With Cetuximab. Dermatologic Surgery. 1–1.
3.
Konicke, Kathryn, et al.. (2018). The microRNA landscape of cutaneous squamous cell carcinoma. Drug Discovery Today. 23(4). 864–870. 21 indexed citations
4.
Jha, Pinky, et al.. (2017). A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis. Case Reports in Dermatological Medicine. 2017. 1–5. 13 indexed citations
5.
Konicke, Kathryn, et al.. (2017). Microneedling in Dermatology: A Review. Plastic Surgical Nursing. 37(3). 112–115. 6 indexed citations
6.
Olasz, Edit, et al.. (2016). What You Didn't Know About the Sun: Infrared Radiation and Its Role in Photoaging. Plastic Surgical Nursing. 36(4). 170–172. 3 indexed citations
7.
Lindsay, Daniel, et al.. (2014). Eruptive keratoacanthomas after radiation therapy for keratoacanthoma centrifugum marginatum. Practical Radiation Oncology. 5(3). 203–206.
9.
Doctrow, Susan R., María Argelia López Luna, Edit Olasz, et al.. (2012). A Synthetic Superoxide Dismutase/Catalase Mimetic EUK-207 Mitigates Radiation Dermatitis and Promotes Wound Healing in Irradiated Rat Skin. Journal of Investigative Dermatology. 133(4). 1088–1096. 51 indexed citations
10.
Luna, María Argelia López, Edit Olasz, Brian L. Fish, et al.. (2011). Laminin 332 Deposition is Diminished in Irradiated Skin in an Animal Model of Combined Radiation and Wound Skin Injury. Radiation Research. 176(5). 636–648. 25 indexed citations
11.
Zenzo, Giovanni Di, Valentina Calabresi, Edit Olasz, Giovanna Zambruno, & Kim B. Yancey. (2009). Sequential Intramolecular Epitope Spreading of Humoral Responses to Human BPAG2 in a Transgenic Model. Journal of Investigative Dermatology. 130(4). 1040–1047. 23 indexed citations
12.
Nishie, Wataru, Daisuke Sawamura, Ken Natsuga, et al.. (2009). A Novel Humanized Neonatal Autoimmune Blistering Skin Disease Model Induced by Maternally Transferred Antibodies. The Journal of Immunology. 183(6). 4088–4093. 24 indexed citations
13.
Lanschuetzer, Christoph M., Edit Olasz, Zelmira Lazarova, & Kim B. Yancey. (2008). Transient Anti-CD40L Co-Stimulation Blockade Prevents Immune Responses against Human Bullous Pemphigoid Antigen 2: Implications for Gene Therapy. Journal of Investigative Dermatology. 129(5). 1203–1207. 7 indexed citations
14.
Elsaie, Mohamed L., et al.. (2008). Cytokines and Langerhans cells in allergic contact dermatitis.. PubMed. 143(3). 195–205. 2 indexed citations
15.
Nishie, Wataru, Daisuke Sawamura, Maki Goto, et al.. (2007). Humanization of autoantigen. Nature Medicine. 13(3). 378–383. 236 indexed citations
16.
Olasz, Edit, Joo Young Roh, Carole Yee, et al.. (2007). Human Bullous Pemphigoid Antigen 2 Transgenic Skin Elicits Specific IgG in Wild-Type Mice. Journal of Investigative Dermatology. 127(12). 2807–2817. 33 indexed citations
17.
Rosenblum, Michael D., Kim B. Yancey, Edit Olasz, & Robert L. Truitt. (2006). CD200, a “no danger” signal for hair follicles. Journal of Dermatological Science. 41(3). 165–174. 56 indexed citations
18.
Rosenblum, Michael, Edit Olasz, Kim B. Yancey, et al.. (2004). Expression of CD200 on Epithelial Cells of the Murine Hair Follicle: A Role in Tissue-Specific Immune Tolerance?. Journal of Investigative Dermatology. 123(5). 880–887. 89 indexed citations
19.
Rosenblum, Michael D., Edit Olasz, Bryon D. Johnson, et al.. (2003). CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood. 103(7). 2691–2698. 67 indexed citations
20.
Kemény, Lajos, et al.. (1994). The interleukin-8 receptor: a potential target for antipsoriatic therapy?. European Journal of Pharmacology. 258(3). 269–272. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026